Blepharoconjunctivitis.
Fazal MI, Patel BC.
2023 Jul 31. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
Dupilumab-Associated Blepharoconjunctivitis: Clinical and Morphological Aspects.
Serino F, Dattilo V, Cennamo M, Roszkowska AM, Gola M, Magliulo M, Magnaterra E, Mencucci R.
Biomedicines. 2023 Nov 21;11(12):3104. doi: 10.3390/biomedicines11123104.
Current Knowledge in Allergic Conjunctivitis.
Villegas BV, Benitez-Del-Castillo JM.
Turk J Ophthalmol. 2021 Feb 25;51(1):45-54. doi: 10.4274/tjo.galenos.2020.11456.
Dupilumab-associated blepharoconjunctivitis.
Paulose SA, Sherman SW, Dagi Glass LR, Suh LH.
Am J Ophthalmol Case Rep. 2019 Sep 5;16:100550. doi: 10.1016/j.ajoc.2019.100550. eCollection 2019 Dec.
Blepharoconjunctivitis.
McCulley JP.
Int Ophthalmol Clin. 1984 Summer;24(2):65-77. doi: 10.1097/00004397-198424020-00009.
Monkeypox Presenting with Blepharoconjunctivitis.
Bloom J, Parise M, Saeed O, Holicki C, Mihok B.
Case Rep Ophthalmol. 2023 Nov 24;14(1):647-653. doi: 10.1159/000533914. eCollection 2023 Jan-Dec.
Demodex blepharitis: clinical perspectives.
Fromstein SR, Harthan JS, Patel J, Opitz DL.
Clin Optom (Auckl). 2018 Jul 4;10:57-63. doi: 10.2147/OPTO.S142708. eCollection 2018.
[Dupilumab-related blepharoconjunctivitis: Recommendations of the CEDRE group. Atopic dermatitis, conjunctivitis and dupilumab: Which management approach?].
Doan S, Arnould L, Febvay C, Fournié P, Gueudry J, Labalette P, Ouilhon C, Tran TH, Vabres B, Barbarot S, Bouaziz JD, Du-Thanh A, Jachiet M, Seneschal J, Soria A, Staumont-Sallé D, Baudouin C, Mortemousque B.
J Fr Ophtalmol. 2022 Mar;45(3):277-287. doi: 10.1016/j.jfo.2021.12.007. Epub 2022 Jan 22.
Unilateral Blepharoconjunctivitis due to Monkeypox Virus Infection.
Scandale P, Raccagni AR, Nozza S.
Ophthalmology. 2022 Nov;129(11):1274. doi: 10.1016/j.ophtha.2022.08.013. Epub 2022 Aug 28.
Ocular manifestations of rosacea: A clinical review.
Tavassoli S, Wong N, Chan E.
Clin Exp Ophthalmol. 2021 Mar;49(2):104-117. doi: 10.1111/ceo.13900. Epub 2021 Feb 3.
